← Leaderboards
Vanita Chopra
Massachusetts General Hospital
$948,750
Attributed
$948,750
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $261K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$948,750 · 2
By mechanism
R21$948,750 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Marilyn S Albert$65,374,594
- Michael A Schwarzschild$27,249,495
- Herminia D Rosas$18,624,312
- Braden Kuo$7,375,946
- Bradley T Hyman$51,936,441
Others in their field
Top investigators on “Neurodegenerative Disorders”
- Adam L Boxer · Mayo Clinic Rochester$61,054,677
- Paul S. Aisen · Cognition Therapeutics, Inc.$56,063,985
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$55,774,157
- Reisa A. Sperling · Banner Health$50,784,577
- Jane S Paulsen · University Of Wisconsin-Madison$38,012,377
- John Q. Trojanowski · University Of Pennsylvania$37,152,274
Research focus
Neurodegenerative DisordersSamplingMonitorNerve DegenerationPlasmaEmotional DisturbanceDisorder ControlInheritedAffectBrainBiological MarkersPathway InteractionsAutopsyCerebrospinal FluidCharacteristicsAmericanHuntington DiseaseClinical TrialsCollectionBody Weight DecreasedDementiaDetectionDisease ProgressionSurveys
Grant awards (4)
miRNA Signatures in Huntington's Disease Plasma and CSF.$213,750
R21 · FY2018 · NS · contact PI
miRNA Signatures in Huntington's Disease Plasma and CSF.$256,500
R21 · FY2017 · NS · contact PI
Mapping Central and Peripheral Metabolomic Markers in Huntington's Disease$261,000
R21 · FY2015 · NS · contact PI
Mapping Central and Peripheral Metabolomic Markers in Huntington's Disease$217,500
R21 · FY2014 · NS · contact PI